Aplastic Anemia Clinical Trials

Not all trials are listed on www.ClinicalTrials.gov. The investigators may have chosen not to register the trial, or the study may not be eligible to be listed on ClinicalTrials.gov. If the study has not, for example, been approved by a human subject review board, it cannot be posted. Some trials are not listed because the investigators are not planning to publish the research findings, so you can ask the study coordinator why the study has not been included on ClinicalTrials.gov before you give your consent to participate.

The information on the studies linked below is provided strictly as a resource, not as an endorsement of any given treatment, doctor, or medical center.

Remember, before you sign a consent form, Clinical Trials Explained can help you understand the potential risks and benefits of a clinical trial. You can also contact the AA&MDSIF staff to discuss any questions you have at clinicaltrials@aamds.org or by calling the office at 301.279.7202 or 800.747.2820.

^{Last Modified: February 2009}

M.D. Anderson Cancer Center

Phase II Study of Combination of Thymoglobulin, Cyclosporine, Methylprednisone, and GCSF in Patients with Newly Diagnosed Aplastic Anemia or with Hypoplastic Myelodysplastic Syndrome

Protocol MDA 2005-0115 | Houston, Texas

This is a phase II trial using Thymoglobulin and Cyclosporine to evaluate the efficacy of Thymoglobulin and Cyclosporine to treat severe aplastic anemia and hypoplastic MDS. Patients with previously untreated severe aplastic anemia or hypoplastic MDS (with bone marrow cellularity less than 30%) who have adequate liver and kidney function are eligible to participate. Contact Dr. Farhad Ravandi at 713.745.0394 or fravandi@mdanderson.org.

For patients with: AA or MDS

Link: http://utm-ext01a.mdacc.tmc.edu/dept/prot/clinicaltrialswp.nsf/index/2005-0115

Updated: December 13, 2007

<< Return to List